New Treatment Options for Transthyretin Cardiac Amyloidosis – What do I need to know?

Clinical Features and Pathophysiology of Transthyretin Cardiac Amyloidosis (TTR-CA) There has been an increasing awareness of the presence of cardiac amyloidosis (CA) in patients presenting with heart failure with preserved left ventricular ejection fraction (HFpEF). The clinical features suggestive of CA are recurrent heart failure with preserved ejection fraction (HFpEF) and restrictive left ventricular filling … Read more